422 related articles for article (PubMed ID: 24839250)
1. Intentions for risk-reducing surgery among high-risk women referred for BRCA1/BRCA2 genetic counseling.
Tong A; Kelly S; Nusbaum R; Graves K; Peshkin BN; Valdimarsdottir HB; Wood M; McKinnon W; Garber J; McCormick SR; Jandorf L; Schwartz MD
Psychooncology; 2015 Jan; 24(1):33-9. PubMed ID: 24839250
[TBL] [Abstract][Full Text] [Related]
2. Predictors of risk-reducing surgery intentions following genetic counseling for hereditary breast and ovarian cancer.
Ladd MK; Peshkin BN; Senter L; Baldinger S; Isaacs C; Segal H; Philip S; Phillips C; Shane K; Martin A; Weinstein V; Pilarski R; Jeter J; Sweet K; Hatten B; Wurtmann EJ; Phippen S; Bro D; Schwartz MD
Transl Behav Med; 2020 May; 10(2):337-346. PubMed ID: 30418620
[TBL] [Abstract][Full Text] [Related]
3. BRCA1/2 test results impact risk management attitudes, intentions, and uptake.
O'Neill SC; Valdimarsdottir HB; Demarco TA; Peshkin BN; Graves KD; Brown K; Hurley KE; Isaacs C; Hecker S; Schwartz MD
Breast Cancer Res Treat; 2010 Dec; 124(3):755-64. PubMed ID: 20383578
[TBL] [Abstract][Full Text] [Related]
4. Women's constructions of the 'right time' to consider decisions about risk-reducing mastectomy and risk-reducing oophorectomy.
Howard AF; Bottorff JL; Balneaves LG; Kim-Sing C
BMC Womens Health; 2010 Aug; 10():24. PubMed ID: 20687957
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance.
Schwartz MD; Isaacs C; Graves KD; Poggi E; Peshkin BN; Gell C; Finch C; Kelly S; Taylor KL; Perley L
Cancer; 2012 Jan; 118(2):510-7. PubMed ID: 21717445
[TBL] [Abstract][Full Text] [Related]
6. Risk-reduction surgery decisions in high-risk women seen for genetic counseling.
Ray JA; Loescher LJ; Brewer M
J Genet Couns; 2005 Dec; 14(6):473-84. PubMed ID: 16388328
[TBL] [Abstract][Full Text] [Related]
7. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Domchek SM; Friebel TM; Singer CF; Evans DG; Lynch HT; Isaacs C; Garber JE; Neuhausen SL; Matloff E; Eeles R; Pichert G; Van t'veer L; Tung N; Weitzel JN; Couch FJ; Rubinstein WS; Ganz PA; Daly MB; Olopade OI; Tomlinson G; Schildkraut J; Blum JL; Rebbeck TR
JAMA; 2010 Sep; 304(9):967-75. PubMed ID: 20810374
[TBL] [Abstract][Full Text] [Related]
8. Breast and ovarian cancer risk perception after prophylactic salpingo-oophorectomy due to an inherited mutation in the BRCA1 or BRCA2 gene.
Finch A; Metcalfe K; Lui J; Springate C; Demsky R; Armel S; Rosen B; Murphy J; Elit L; Sun P; Narod S
Clin Genet; 2009 Mar; 75(3):220-4. PubMed ID: 19263514
[TBL] [Abstract][Full Text] [Related]
9. Cancer prevention and screening practices among women at risk for hereditary breast and ovarian cancer after genetic counseling in the community setting.
Morgan D; Sylvester H; Lucas FL; Miesfeldt S
Fam Cancer; 2009; 8(4):277-87. PubMed ID: 19347608
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes of risk-reducing surgery in unaffected women at increased familial risk of breast and/or ovarian cancer.
Heiniger L; Butow PN; Coll J; Bullen T; Wilson J; Baylock B; Meiser B; Price MA
Fam Cancer; 2015 Mar; 14(1):105-15. PubMed ID: 25283514
[TBL] [Abstract][Full Text] [Related]
11. Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation.
Meijers-Heijboer EJ; Verhoog LC; Brekelmans CT; Seynaeve C; Tilanus-Linthorst MM; Wagner A; Dukel L; Devilee P; van den Ouweland AM; van Geel AN; Klijn JG
Lancet; 2000 Jun; 355(9220):2015-20. PubMed ID: 10885351
[TBL] [Abstract][Full Text] [Related]
12. Key messages for communicating information about BRCA1 and BRCA2 to women with breast or ovarian cancer: Consensus across health professionals and service users.
Jacobs C; Pichert G; Harris J; Tucker K; Michie S
Psychooncology; 2017 Nov; 26(11):1818-1824. PubMed ID: 28101941
[TBL] [Abstract][Full Text] [Related]
13. Impact of family history on choosing risk-reducing surgery among BRCA mutation carriers.
Singh K; Lester J; Karlan B; Bresee C; Geva T; Gordon O
Am J Obstet Gynecol; 2013 Apr; 208(4):329.e1-6. PubMed ID: 23333547
[TBL] [Abstract][Full Text] [Related]
14. Attitude towards hereditary cancer risk management among women with cancer in Taiwan.
Fang SY; Hsieh LL; Hung CF; Hung FH; Peng HP; Yang AS; Wang YA
Support Care Cancer; 2022 Apr; 30(4):3625-3632. PubMed ID: 35028717
[TBL] [Abstract][Full Text] [Related]
15. Testing for hereditary breast and ovarian cancer in the southeastern United States.
Miron A; Schildkraut JM; Rimer BK; Winer EP; Sugg Skinner C; Futreal PA; Culler D; Calingaert B; Clark S; Kelly Marcom P; Iglehart JD
Ann Surg; 2000 May; 231(5):624-34. PubMed ID: 10767783
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with intentions for breast cancer risk management: Does risk group matter?
Conley CC; Agnese DM; Vadaparampil ST; Andersen BL
Psychooncology; 2019 May; 28(5):1119-1126. PubMed ID: 30889627
[TBL] [Abstract][Full Text] [Related]
17. Characterizing biased cancer-related cognitive processing: relationships with BRCA1/2 genetic mutation status, personal cancer history, age, and prophylactic surgery.
Carpenter KM; Eisenberg S; Weltfreid S; Low CA; Beran T; Stanton AL
Health Psychol; 2014 Sep; 33(9):1003-11. PubMed ID: 23772886
[TBL] [Abstract][Full Text] [Related]
18. Adaptation of couples living with a high risk of breast/ovarian cancer and the association with risk-reducing surgery.
Shapira R; Turbitt E; Erby LH; Biesecker BB; Klein WMP; Hooker GW
Fam Cancer; 2018 Oct; 17(4):485-493. PubMed ID: 29209897
[TBL] [Abstract][Full Text] [Related]
19. Psychological factors associated with the intention to choose for risk-reducing mastectomy in family cancer clinic attendees.
van Driel CMG; Oosterwijk JC; Meijers-Heijboer EJ; van Asperen CJ; Zeijlmans van Emmichoven IA; de Vries J; Mourits MJE; Henneman L; Timmermans DRM; de Bock GH
Breast; 2016 Dec; 30():66-72. PubMed ID: 27639031
[TBL] [Abstract][Full Text] [Related]
20. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Nelson HD; Pappas M; Cantor A; Haney E; Holmes R
JAMA; 2019 Aug; 322(7):666-685. PubMed ID: 31429902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
